The burden of disease in Spain: results from the global burden of disease study 2010

被引:26
|
作者
Maria Haro, Josep [1 ,2 ]
Tyrovolas, Stefanos [1 ,2 ]
Garin, Noe [1 ,2 ]
Diaz-Torne, Cesar [3 ]
Carmona, Loreto [4 ]
Sanchez-Riera, Lidia [5 ,6 ]
Perez-Ruiz, Fernando [7 ]
Murray, Christopher J. L. [8 ]
机构
[1] Univ Barcelona, Fdn Sant Joan de Du, Parc Sanitari Sant Joan de Du, Barcelona 08830, Spain
[2] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid 28007, Spain
[3] Univ Autonoma Barcelona, Hosp Santa Creu I Sant Pau, Unitat Reumatol, Barcelona 08026, Spain
[4] Inst Salud Musculoesquelt InMusc, Madrid 28015, Spain
[5] Univ Sydney, Royal N Shore Hosp, Inst Bone & Joint Res, St Leonards, NSW 2065, Australia
[6] Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge, Barcelona 08907, Spain
[7] Cruces Univ Hosp, BioCruces Hlth Invest Inst, Div Rheumatol, Crystal Induced Arthrit Invest Team, Baracaldo 48903, Spain
[8] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA
来源
BMC MEDICINE | 2014年 / 12卷
基金
比尔及梅琳达.盖茨基金会;
关键词
Disability-adjusted life years; Global Burden of Diseases; Injuries; and Risk Factors Studies; Spain; Mortality; Years lived with disability; Years of life lost; SYSTEMATIC ANALYSIS; RISK-FACTORS; HEALTH; MORTALITY; BACK; AGE; REGIONS; INJURY;
D O I
10.1186/s12916-014-0236-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We herein evaluate the Spanish population s trends in health burden by comparing results of two Global Burden of Diseases, Injuries, and Risk Factors Studies (the GBD studies) performed 20 years apart. Methods: Data is part of the GBD study for 1990 and 2010. We present results for mortality, years of life lost (YLLs), years lived with disability, and disability-adjusted life years (DALYs) for the Spanish population. Uncertainty intervals for all measures have been estimated. Results: Non-communicable diseases accounted for 3,703,400 (95% CI 3,648,270 3,766,720) (91.3%) of 4,057,400 total deaths, in the Spanish population. Cardiovascular and circulatory diseases were the main cause of mortality among non-communicable diseases (34.7% of total deaths), followed by neoplasms (27.1% of total deaths). Neoplasms, cardiovascular and circulatory diseases, and chronic respiratory diseases were the top three leading causes for YLLs. The most important causes of DALYs in 2010 were neoplasms, cardiovascular and circulatory diseases, musculoskeletal disorders, and mental and behavioral disorders. Conclusions: Mortality and disability in Spain have become even more linked to non-communicable diseases over the last years, following the worldwide trends. Cardiovascular and circulatory diseases, neoplasms, mental and behavioral disorders, and neurological disorders are the leading causes of mortality and disability. Specific focus is needed from health care providers and policy makers to develop health promotion and health education programs directed towards non-communicable disorders.
引用
收藏
页数:25
相关论文
共 50 条
  • [42] Incidence and disease burden of prostate cancer from 1990 to 2017: Results from the Global Burden of Disease Study 2017
    Zhai, Zhen
    Zheng, Yi
    Li, Na
    Deng, Yujiao
    Zhou, Linghui
    Tian, Tian
    Yang, Si
    Hao, Qian
    Song, Dingli
    Wu, Ying
    Zhang, Dai
    Dai, Zhijun
    Wang, Ziming
    CANCER, 2020, 126 (09) : 1969 - 1978
  • [43] Disease burden in the Nordic region. Results from the Global Burden of Disease Study 2017 (GBD 2017)
    Knudsen, Ann Kristin
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29 : 65 - 65
  • [44] The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010
    Whiteford, Harvey A.
    Ferrari, Alize J.
    Degenhardt, Louisa
    Feigin, Valery
    Vos, Theo
    PLOS ONE, 2015, 10 (02):
  • [45] The global burden of occupationally related low back pain: estimates from the Global Burden of Disease 2010 study
    Driscoll, T.
    Jacklyn, G.
    Orchard, J.
    Passmore, E.
    Vos, T.
    Freedman, G.
    Lim, S.
    Punnett, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) : 975 - 981
  • [46] The burden of leishmaniasis in Iran: findings from the global burden of disease from 1990 to 2010
    Badirzadeh, A.
    Asadgol, Z.
    Spotin, A.
    Mokhayeri, Y.
    Shirzadi, M. R.
    Zeinali, M.
    Mohebali, M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 212 - 212
  • [47] Changing epidemiology of cirrhosis from 2010 to 2019: results from the Global Burden Disease study 2019
    Xiao, Shiyu
    Xie, Wenhui
    Zhang, Yinghui
    Lei, Lei
    Pan, Yan
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [48] Forecasting and Analyzing the Disease Burden of Aged Population in China, Based on the 2010 Global Burden of Disease Study
    Bao, Chengzhen
    Mayila, Mamat
    Ye, Zhenhua
    Wang, Jianbing
    Jin, Mingjuan
    He, Wenjiong
    Chen, Kun
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2015, 12 (07) : 7172 - 7184
  • [49] The burden of liver cirrhosis and underlying etiologies: results from the Global Burden of Disease Study 2019
    Lan, Yan
    Wang, Hao
    Weng, Haoda
    Xu, Xianbin
    Yu, Xia
    Tu, Huilan
    Gong, Kai
    Yao, Junjie
    Ye, Shaoheng
    Shi, Yu
    Sheng, Jifang
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (02) : E0026
  • [50] The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017
    Zhai, Mimi
    Long, Jianhai
    Liu, Sushun
    Liu, Chun
    Li, Li
    Yang, Leping
    Li, Yamin
    Shu, Bo
    AGING-US, 2021, 13 (01): : 279 - 300